558 related articles for article (PubMed ID: 11078524)
1. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
Zhang Y; Gao J; Chung KK; Huang H; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13354-9. PubMed ID: 11078524
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
3. Part I: parkin-associated proteins and Parkinson's disease.
Dev KK; van der Putten H; Sommer B; Rovelli G
Neuropharmacology; 2003 Jul; 45(1):1-13. PubMed ID: 12814656
[TBL] [Abstract][Full Text] [Related]
4. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
Imai Y; Soda M; Takahashi R
J Biol Chem; 2000 Nov; 275(46):35661-4. PubMed ID: 10973942
[TBL] [Abstract][Full Text] [Related]
5. Drosophila melanogaster Parkin ubiquitinates peanut and septin1 as an E3 ubiquitin-protein ligase.
Bae YJ; Kang SJ; Park KS
Insect Biochem Mol Biol; 2007 May; 37(5):430-9. PubMed ID: 17456438
[TBL] [Abstract][Full Text] [Related]
6. Parkin and Parkinson's disease.
Mizuno Y; Hattori N; Mori H; Suzuki T; Tanaka K
Curr Opin Neurol; 2001 Aug; 14(4):477-82. PubMed ID: 11470964
[TBL] [Abstract][Full Text] [Related]
7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements.
Rankin CA; Joazeiro CA; Floor E; Hunter T
J Biomed Sci; 2001 Sep; 8(5):421-9. PubMed ID: 11549885
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity.
Kazlauskaite A; Kelly V; Johnson C; Baillie C; Hastie CJ; Peggie M; Macartney T; Woodroof HI; Alessi DR; Pedrioli PG; Muqit MM
Open Biol; 2014 Mar; 4(3):130213. PubMed ID: 24647965
[TBL] [Abstract][Full Text] [Related]
10. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
11. U box proteins as a new family of ubiquitin-protein ligases.
Hatakeyama S; Yada M; Matsumoto M; Ishida N; Nakayama KI
J Biol Chem; 2001 Aug; 276(35):33111-20. PubMed ID: 11435423
[TBL] [Abstract][Full Text] [Related]
12. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.
Shimura H; Hattori N; Kubo Si; Mizuno Y; Asakawa S; Minoshima S; Shimizu N; Iwai K; Chiba T; Tanaka K; Suzuki T
Nat Genet; 2000 Jul; 25(3):302-5. PubMed ID: 10888878
[TBL] [Abstract][Full Text] [Related]
13. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
Im E; Yoo L; Hyun M; Shin WH; Chung KC
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
[TBL] [Abstract][Full Text] [Related]
14. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
Nat Commun; 2013; 4():1983. PubMed ID: 23770917
[TBL] [Abstract][Full Text] [Related]
15. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
16. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
17. Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for degradation.
Chin LS; Vavalle JP; Li L
J Biol Chem; 2002 Sep; 277(38):35071-9. PubMed ID: 12121982
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.
Dong Z; Ferger B; Paterna JC; Vogel D; Furler S; Osinde M; Feldon J; Büeler H
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12438-43. PubMed ID: 14530399
[TBL] [Abstract][Full Text] [Related]
19. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
